Meitheal Pharmaceuticals, Inc.
Founded in 2017, Meitheal Pharmaceuticals, Inc. is a fully integrated biopharmaceutical company based in Chicago, focused on developing and commercializing generic injectables, fertility, biologic, and branded products. Meitheal markets over 60 FDA-approved products across various therapeutic areas, including anti-infectives, oncolytics, intensive care, and fertility. As of August 2024, they have over 20 products in research and development, successfully launched 8 new products with 6 additional planned by end of 2024, 21 under FDA review. Ranked #2 on Crain's Fast 50 and Best Places to Work (Chicago) in 2024, Meitheal embodies its namesake, the Irish principle of working together for the greater good.